Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Trifast warns on full-year results, shares tank

(Sharecast News) - Trifast tanked on Monday as it warned that full-year results would be "significantly" below its previous expectations, pointing to low visibility and volatile demand. For the year to the end of March, the company now expects revenue of around £230m and an adjusted EBIT margin percentage of around 5%.

Trifast, which specialises in the design, engineering, manufacture, and distribution of industrial fastenings, said that as reported in the interim results in November, trading were characterised by low visibility and volatile demand in a number of end market and geographic segments.

"Disappointingly, performance in December 2023 was impacted by significantly lower than forecasted volumes in both our Asia operations and global distribution sales channel," it said.

"Whilst we had anticipated both of these areas to see a recovery from subdued activity in H1, demand conditions and excess customer inventory levels have pushed this recovery further into 2024 and we now expect these challenging conditions to persist through to the end of the financial year."

Given the weak outlook, Trifast also announced plans to further reduce operating costs through a cutback of around 10% in its non-operational staff globally. This is expected to deliver annualised savings of around £3m.

"As part of the restructure, we will establish a leaner organisational structure to enable faster decision making. In parallel, we are undertaking a strategic review of our global footprint to identify further cost efficiencies which will reset our business for the future," it said.

At 1050 GMT, the shares were down 14% at 80.40p.

Share this article

Related Sharecast Articles

Eli Lilly weight-loss drug 'significantly' reduces sleep apnoea
(Sharecast News) - Eli Lily's weight-loss drug tirzepatide has been shown to "significantly" reduce sleep apnoea severity, the US drugs giant said on Wednesday.
Royal Mail-owner rebuffs takeover approach
(Sharecast News) - Shares in International Distribution Services soared on Wednesday, after it emerged that Czech billionaire Daniel Kretinsky had made a takeover approach for the Royal Mail owner.
Just Eat shares drop as Q1 orders disappoint
(Sharecast News) - Shares in Just Eat dropped sharply on Wednesday after the food delivery marketplace delivered underwhelming order numbers for the first quarter, though revenue growth picked up sharply in the UK and Ireland.
Tekcapital's Innovative Eyewear inks deal with US firm
(Sharecast News) - Intellectual property investor Tekcapital announced a fresh development from its portfolio company Innovative Eyewear on Wednesday, as the latter launched a strategic partnership with Windsor Eyes, a prominent eyewear manufacturing and distribution firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.